Adult Stromal Cells Derived from Human Adipose Tissue Provoke Pancreatic Cancer Cell Death both In Vitro and In Vivo

Béatrice Cousin(Université Fédérale de Toulouse Midi-Pyrénées), Emmanuel Ravet(Centre National de la Recherche Scientifique), Sandrine Poglio(Université Toulouse III - Paul Sabatier), Fabienne de Toni(Université Toulouse III - Paul Sabatier), Mélanie Bertuzzi(Université Fédérale de Toulouse Midi-Pyrénées), Hubert Lulka(Inserm), Touil Ismahane(Centre National de la Recherche Scientifique), Mireille André(Université Fédérale de Toulouse Midi-Pyrénées), Jean-Louis Grolleau(Centre Hospitalier Universitaire de Toulouse), Jean‐Marie Péron(Inserm), J.-P. Chavoin(Centre Hospitalier Universitaire de Toulouse), Philippe Bourin(Laboratoire de Génétique Cellulaire), Luc Pénicaud(Université Toulouse III - Paul Sabatier), Louis Casteilla(Université Fédérale de Toulouse Midi-Pyrénées), Louis Buscail(Inserm), Pierre Cordelier(Inserm)
PLoS ONE
July 16, 2009
Cited by 262Open Access
Full Text

Abstract

BACKGROUND: Normal tissue homeostasis is maintained by dynamic interactions between epithelial cells and their microenvironment. Disrupting this homeostasis can induce aberrant cell proliferation, adhesion, function and migration that might promote malignant behavior. Indeed, aberrant stromal-epithelial interactions contribute to pancreatic ductal adenocarcinoma (PDAC) spread and metastasis, and this raises the possibility that novel stroma-targeted therapies represent additional approaches for combating this malignant disease. The aim of the present study was to determine the effect of human stromal cells derived from adipose tissue (ADSC) on pancreatic tumor cell proliferation. PRINCIPAL FINDINGS: Co-culturing pancreatic tumor cells with ADSC and ADSC-conditioned medium sampled from different donors inhibited cancer cell viability and proliferation. ADSC-mediated inhibitory effect was further extended to other epithelial cancer-derived cell lines (liver, colon, prostate). ADSC conditioned medium induced cancer cell necrosis following G1-phase arrest, without evidence of apoptosis. In vivo, a single intra-tumoral injection of ADSC in a model of pancreatic adenocarcinoma induced a strong and long-lasting inhibition of tumor growth. CONCLUSION: These data indicate that ADSC strongly inhibit PDAC proliferation, both in vitro and in vivo and induce tumor cell death by altering cell cycle progression. Therefore, ADSC may constitute a potential cell-based therapeutic alternative for the treatment of PDAC for which no effective cure is available.


Related Papers

No related papers found

Powered by citation graph analysis